Anne Madroszyk-Flandin

Suggest Changes
Learn More
4118 Background: The survival of patients (pts) with locally advanced or metastatic pancreatic cancer could be improved by the addition of P to standard chemotherapy with G. METHODS The primary(More)
INTRODUCTION Paclitaxel plus cisplatin is considered to be the standard first-line therapy for advanced ovarian cancer. Previous to this study, economic data on this combination resulted from(More)
  • 1